News

Anti-vascular endothelial growth factor (anto-VEGF) monotherapy is inadequate in patients with age-related macular degeneration (AMD). However, by adding an anti-platelet-derived growth factor (anti-PDGF) drug to the anti-VEGF regimen, treatment is enhanced by preventing the development of fibrosis thus improving visual outcomes, according to Usha Chakravarthy, MBBS, PhD.

It has been established that implementing electronic health records (EHR) has not been well received by physicians. Complaints of EHR costs and complications are among a laundry list of concerns physicians have voiced since the system’s mandated adoption. Ophthalmology Times asked three EHR experts to list the most common complaints they have heard physicians experience while addressing the implementation, and their advice on solving these issues.

A laser tissue bonding apparatus integrated with an optical coherence tomography (OCT) probe is a plausible instrument that allows for temperature-controlled laser bonding of incisions in the cornea, according to Israeli researchers. The OCT probe can provide real-time feedback of structural change of the corneal tissue, and indicate the progress and end point of the bonding.

A team of researchers from Denmark believes it has found a way for ophthalmologists to identify the patients who will most likely to benefit from age-related cataract surgery.

No doubt, my retina colleagues are way ahead of me in considering this issue. Reducing the frequency of injections by developing longer-lasting therapeutic agents and reducing the per-injection risk by careful scrutiny of evidence to determine the best practice when it comes to injection protocols are two possibilities.

The eyewear market is changing more rapidly than ever, and it is no longer acceptable to sell the same way to each consumer. Staying up-to-date on how to leverage unique marketing to every generation is the key to success.

One surgeon’s experiences with the iStent trabecular micro bypass; an implant that forms a patent opening through the trabecular meshwork into Schlemm’s canal, restoring physiological aqueous outflow and providing a significant and sustained decrease in IOP.

In this article, Dr Johannson presents intraindividual IOL comparison follow-up results. Although similar levels of PCO development were observed for both AcrySof and Tecnis one-piece IOLs, fewer glistenings appeared in the Tecnis material, 3 years after implantation.

A protein called PKal (plasma kallikrein) and its associated molecules are key players in an inflammatory molecular pathway involved in diabetic macular edema, according to a study published in Diabetes.